IRIS
BIANCHERI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 809
EU - Europa 521
AS - Asia 471
OC - Oceania 3
SA - Sud America 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.808
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 806
CN - Cina 449
IE - Irlanda 205
FI - Finlandia 94
UA - Ucraina 69
DE - Germania 59
SE - Svezia 31
GB - Regno Unito 23
IT - Italia 18
SG - Singapore 18
BE - Belgio 11
FR - Francia 5
AU - Australia 3
CA - Canada 3
IN - India 2
NL - Olanda 2
BR - Brasile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EU - Europa 1
HU - Ungheria 1
IR - Iran 1
LV - Lettonia 1
MA - Marocco 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 1.808
Salva come PNG Salva come JPEG
Città #
Chandler 209
Dublin 203
Jacksonville 126
Nanjing 121
Ann Arbor 57
Beijing 53
Boardman 50
Nanchang 48
Ashburn 42
Changsha 42
Shenyang 37
Hebei 36
Lawrence 36
Princeton 36
Wilmington 34
Jiaxing 30
Helsinki 26
Tianjin 21
Shanghai 19
Hangzhou 18
Medford 17
Dearborn 15
Brussels 11
Milan 9
Singapore 9
Fairfield 7
Woodbridge 6
Norwalk 4
Berlin 3
Jinan 3
Kunming 3
Los Angeles 3
San Francisco 3
Verona 3
Canberra 2
Dallas 2
Des Moines 2
Falkenstein 2
New York 2
Pune 2
Seattle 2
Taizhou 2
Toronto 2
Bloomfield 1
Guangzhou 1
Haikou 1
Hefei 1
Houston 1
Lanzhou 1
Melbourne 1
Ningbo 1
Pavia 1
Prague 1
Quito 1
Rabat 1
Rome 1
Sassari 1
São Paulo 1
Tappahannock 1
Walnut 1
Yurga 1
Zhengzhou 1
Totale 1.377
Salva come PNG Salva come JPEG
Nome #
Peripheral regulatory T cells and serum transforming growth factor-β: relationship with clinical response to infliximab in Crohn's disease. 87
Involvement of CD40-CD40 ligand in uncomplicated and refractory celiac disease. 87
Abnormal anandamide metabolism in celiac disease. 87
Effect of tumor necrosis factor-alpha blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease 75
Splenic hypofunction in whipple's disease. 66
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. 64
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease 64
Fibroblast activation protein expression in Crohn's disease strictures 63
Impairment of splenic IgM-memory but not switched-memory B cells in a patient with celiac disease and splenic atrophy. 63
Peripheral regulatory T cells and serum transforming growth factor-β: relationship with clinical response to infliximab in Crohn's disease. 60
Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease. 58
Absence of a role for interleukin-13 in inflammatory bowel disease 58
Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease. 57
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease. 54
Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab. 53
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment. 53
New pathogenic paradigms in inflammatory bowel disease. 53
Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab. 50
Detection of Mycobacterium avium subsp. paratuberculosis (MAP)-specific IS900 DNA and antibodies against MAP peptides and lysate in the blood of Crohn's disease patients. 48
Stromelysin-1 and macrophage metalloelastase expression in the intestinal mucosa of Crohn’s disease patients treated with infliximab 47
Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease. 47
Optimal use and cost-effectiveness of biologic therapies in inflammatory bowel disease. 47
In Crohn's disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts 47
The role of transforming growth factor (TGF)-β in modulating the immune response and fibrogenesis in the gut 45
Impairment of splenic IgM-memory but not switched-memory B cells in a patient with celiac disease and splenic atrophy. 44
Innate and adaptive immunity in inflammatory bowel disease 44
Proteolytic Cleavage and Loss of Function of Biologic Agents That Neutralize Tumor Necrosis Factor in the Mucosa of Patients with Inflammatory Bowel Disease 42
Epithelial down-regulation of the miR-200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition. 40
Proteases and the gut barrier. 40
Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies 39
Distribution, proliferation, and function of Paneth cells in uncomplicated and complicated adult celiac disease. 39
Small Amounts of Gluten in Subjects With Suspected Nonceliac Gluten Sensitivity: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial 39
The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis 33
Low serum levels of microRNA-19 are associated with a stricturing Crohn's disease phenotype 33
Recent advances in understanding ulcerative colitis. 30
Proteases and small intestinal barrier function in health and disease 25
Totale 1.881
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.636
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020152 0 0 0 16 1 25 7 23 3 50 26 1
2020/2021166 16 13 6 15 0 18 1 36 6 28 22 5
2021/2022136 2 3 0 1 4 0 1 11 9 2 25 78
2022/2023571 79 59 3 47 54 52 0 33 232 2 7 3
2023/2024155 24 51 1 7 10 37 3 8 1 8 5 0
2024/202564 6 42 13 3 0 0 0 0 0 0 0 0
Totale 1.881